The INDICAID™ COVID-19 Rapid Antigen Test (FDA EUA) is a lateral flow immunoassay designed for the qualitative detection of SARS-CoV-2 antigens in direct nasal swab samples.

Product Advantage

Quick: With INDICAID, users can expect quick results in just 20 minutes.

Easy: User-friendly testing. No additional equipment or training is required.

Simple Sampling: INDICAID comes with intuitive vials to obtain self-collected shallow nasal samples.

Bulk Testing: Our rapid COVID-19 test offers bulk sample collection and testing, great for high volume screening.

For In Vitro Diagnostic Use Only

EUA 210259

Professional Use Only

Principle

The INDICAID COVID-19 Rapid Antigen Test Rapid detects antigens from SARS-CoV-2 virus and can be used for COVID-19 screening during active infection


Specifications

FeaturesSpecifications
Product code
2110400

Items per box
25x

Specimen type
Direct Anterior Nasal swab
Intended use
Qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 in direct nasal swab samples from individuals who are suspected of COVID-19 by their healthcare provider within the first five (5) days of symptom onset
Storage condition

2-8ºC. Do not freeze. Avoid direct sunlight

Product Sales and Customer Services

Sales Email: ussales@phasesci.com

Technical
Support :

US

+1 (657) 296-6106 (9am – 6pm Pacific)

Please Complete the Form Below to Contact Sales.